The initial seven days on semaglutide mark a period of adjustment as the body begins to respond to the medication. This phase is characterized by the introduction of a glucagon-like peptide-1 (GLP-1) receptor agonist, which aims to regulate blood sugar levels and potentially induce weight loss. Dosage typically starts low to minimize potential side effects.
Understanding the initial effects of semaglutide is vital for patient adherence and overall treatment success. Proper management of potential side effects during this time can lead to improved long-term outcomes. Awareness of common reactions and strategies to mitigate discomfort contribute to a more positive experience and encourage continuation of the prescribed regimen.